Mowi Acknowledges “Biologically Challenging” Q1 in Norway
Mowi released its Q1 2024 results this week, reporting revenues of 1.33 billion euros in the first quarter, compared to 1.36 billion euros in Q1 2023. Mowi CEO Ivan Vindheim chalked up the decrease in revenue to “challenges” related to a cold winter, winter sores and an “unusually high prevalence of string jellyfish."
“Consequently, I am pleased to see the situation in Norway has improved considerably in the second quarter,” said Vindheim. “We are now vaccinating our smolt with an improved winter sore vaccine which has...
To Read Full Story Login Below.